Abstract
A three-dimensional model of the malarial drug target protein PfDXR was generated, and validated using structure-checking programs and protein docking studies. Structural and functional features unique to PfDXR were identified using the model and comparative sequence analyses with apicomplexan and non-apicomplexan DXR proteins. Furthermore, we have used the model to develop an efficient approach to screen for potential tool compounds for use in the rational design of novel DXR inhibitors.
Keywords: PfDXR, antimalarial, apicomplexan, inhibitors, fosmidomycin, binding affinity, IC50
Protein & Peptide Letters
Title: The Malarial Drug Target Plasmodium falciparum 1-Deoxy-D-Xylulose-5- Phosphate Reductoisomerase (PfDXR): Development of a 3-D Model for Identification of Novel, Structural and Functional Features and for Inhibitor Screening (Supplementary Information)
Volume: 17 Issue: 1
Author(s): Jessica L. Goble, Matthew R. Adendorff, Tjaart A.P. de Beer, Linda L. Stephens and Gregory L. Blatch
Affiliation:
Keywords: PfDXR, antimalarial, apicomplexan, inhibitors, fosmidomycin, binding affinity, IC50
Abstract: A three-dimensional model of the malarial drug target protein PfDXR was generated, and validated using structure-checking programs and protein docking studies. Structural and functional features unique to PfDXR were identified using the model and comparative sequence analyses with apicomplexan and non-apicomplexan DXR proteins. Furthermore, we have used the model to develop an efficient approach to screen for potential tool compounds for use in the rational design of novel DXR inhibitors.
Export Options
About this article
Cite this article as:
Goble L. Jessica, Adendorff R. Matthew, de Beer A.P. Tjaart, Stephens L. Linda and Blatch L. Gregory, The Malarial Drug Target Plasmodium falciparum 1-Deoxy-D-Xylulose-5- Phosphate Reductoisomerase (PfDXR): Development of a 3-D Model for Identification of Novel, Structural and Functional Features and for Inhibitor Screening (Supplementary Information), Protein & Peptide Letters 2010; 17 (1) . https://dx.doi.org/10.2174/092986610789909548
DOI https://dx.doi.org/10.2174/092986610789909548 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Targeting the Transcriptional and Translational Machinery of the Endosymbiotic Organelle in Apicomplexans
Current Drug Targets Tailoring Small Proteins Towards Biomedical Applications
Current Pharmaceutical Biotechnology A Case of Fingolimod-associated Cryptococcal Meningitis
Current HIV Research Hepatic Diseases Related to Triglyceride Metabolism
Mini-Reviews in Medicinal Chemistry Passive Smoking, Asthma and Allergy in Children
Inflammation & Allergy - Drug Targets (Discontinued) Macrophage Migration Inhibitory Factor and the Discovery of Tautomerase Inhibitors
Current Pharmaceutical Design <i>Trigonella foenum-graecum</i> Seeds Oil Attenuated Inflammation and Angiogenesis in vivo through Down-Regulation of TNF-α
Anti-Cancer Agents in Medicinal Chemistry Total Tannin Content and Antidiarrheal Activity of Tecomaria capensis Leaves Extract
The Natural Products Journal Protein Tyrosine Phosphatase SHP-2 as Drug Target
Mini-Reviews in Organic Chemistry Recent Development of Drug Delivery Systems for the Treatment of Asthma and Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Identification of Tumor Targeting Agents by Phage Display
Medicinal Chemistry Reviews - Online (Discontinued) Autophagy and Crohns Disease: At the Crossroads of Infection, Inflammation, Immunity, and Cancer
Current Molecular Medicine Retinoic Acid and the Gut Microbiota in Alzheimer’s Disease: Fighting Back-to-Back?
Current Alzheimer Research Proteinase-Activated Receptor 2 (PAR2): A Challenging New Target for Treatment of Vascular Diseases
Current Pharmaceutical Design Computational Tools in the Discovery of New G-Quadruplex Ligands with Potential Anticancer Activity
Current Topics in Medicinal Chemistry Incretins and Preservation of Endothelial Function
Cardiovascular & Hematological Agents in Medicinal Chemistry Perivascular Adipose Tissue, Inflammation and Vascular Dysfunction in Obesity
Current Vascular Pharmacology Nanotechnology Platforms in Diagnosis and Treatment of Primary Brain Tumors
Recent Patents on Nanotechnology